Example: Heart Attack

Clinical Trials Sponsored by Ardea Biosciences, Inc

Total 38 results

    • NCT03272425
      Completed
      Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence.
      Conditions: Gout
    • NCT02888054
      Completed
      Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence
      Conditions: Healthy
    • NCT02608710
      Completed
      RDEA3170 PK/PD Study
      Conditions: Gout
    • NCT02581553
      Completed
      Lesinurad/Allopurinol 200/300 FDC Tablets Bioavailability
      Conditions: Healthy
    • NCT02498652
      Completed
      Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects
      Conditions: Gout
    • NCT02448368
      Completed
      RDEA3170 Tablet and Capsule Bioavailability Study
      Conditions: Healthy
    • NCT02398448
      Completed
      IVIVR Assessing PK Parameters Used to Establish Bioequivalence
      Conditions: Healthy
    • NCT02393560
      Completed
      DECT Study in Allopurinol-Treated Gout Patients
      Conditions: Gout
    • NCT02336594
      Completed
      RDEA3170 Bioavailability Study
      Conditions: Gout
    • NCT02279641
      Completed
      RDEA3170 and Allopurinol Combination Study in Gout Subjects
      Conditions: Gout
    • NCT02246673
      Completed
      RDEA3170 and Febuxostat Combination Study in Gout Subjects
      Conditions: Gout
    • NCT02219516
      Completed
      Mild, Moderate and Severe Renal Impairment Study
      Conditions: Gout
    • NCT02127775
      Completed
      Lesinurad Tablet Bioequivalence
      Conditions: Healthy
    • NCT02039700
      Completed
      Bioavailability of Lesinurad and Intravenous [14C]Lesinurad
      Conditions: Healthy
    • NCT02028689
      Completed
      Metformin and Furosemide Drug-Drug Interaction Study
      Conditions: Healthy
    • NCT01986556
      Completed
      Lesinurad Tablet Relative Bioavailability
      Conditions: Healthy
    • NCT01982201
      Completed
      Antacid Interaction Study
      Conditions: Healthy
    • NCT01927198
      Completed
      RDEA3170 Monotherapy in Subjects With Gout
      Conditions: Gout
    • NCT01910506
      Completed
      RDEA3170 AME Study
      Conditions: Healthy
    • NCT01908257
      Completed
      Lesinurad Interaction Study With Ranitidine
      Conditions: Healthy
    • NCT01884272
      Completed
      NSAID Drug Interaction Study
      Conditions: Gout
    • NCT01883167
      Completed
      RDEA3170 and Febuxostat Drug Interaction Study
      Conditions: Healthy
    • NCT01872832
      Completed
      Single and Multiple Dose Study in Japanese Subjects
      Conditions: Gout
    • NCT01808144
      Completed
      Lesinurad and Febuxostat Combination Extension Study in Gout
      Conditions: Gout
    • NCT01808131
      Completed
      Lesinurad and Allopurinol Combination Extension Study in Gout
      Conditions: Gout
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations